glp-1 drugs lawsuit Medications GLP-1 Lawsuit | Stomach Paralysis,
Description
#thirdcause
Exec SummaryDanuglipron is an experimental weight loss medication being developed by Pfizer
A dietitian breaks down the science behind the hype and how they really work.
Here's a breakdown of what we know so far: Type of Drug: Danuglipron belongs to a class of drugs called GLP-1 receptor agonists
Experts warn that misuse of Ozempic and Mounjaro could trigger serious health risks without medical supervision.
